Suppr超能文献

冠状动脉疾病一级、二级和三级预防的现状

Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease.

作者信息

Prasad Kailash

机构信息

Department of Physiology (APP), College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

出版信息

Int J Angiol. 2021 Aug 25;30(3):177-186. doi: 10.1055/s-0041-1731273. eCollection 2021 Sep.

Abstract

Fifty percent of all death from cardiovascular diseases is due to coronary artery disease (CAD). This is avoidable if early identification is made. Preventive health care has a major role in the fight against CAD. Atherosclerosis and atherosclerotic plaque rupture are involved in the development of CAD. Modifiable risk factors for CAD are dyslipidemia, diabetes, hypertension, cigarette smoking, obesity, chronic renal disease, chronic infection, high C-reactive protein, and hyperhomocysteinemia. CAD can be prevented by modification of risk factors. This paper defines the primary, secondary, and tertiary prevention of CAD. It discusses the mechanism of risk factor-induced atherosclerosis. This paper describes the CAD risk score and its use in the selection of individuals for primary prevention of CAD. Guidelines for primary, secondary, and tertiary prevention of CAD have been described. Modification of risk factors and use of guidelines for prevention of CAD would prevent, regress, and slow down the progression of CAD, improve the quality of life of patient, and reduce the health care cost.

摘要

所有心血管疾病导致的死亡中,有50%归因于冠状动脉疾病(CAD)。如果能早期识别,这是可以避免的。预防性医疗保健在对抗CAD方面发挥着重要作用。动脉粥样硬化和动脉粥样硬化斑块破裂与CAD的发展有关。CAD的可改变风险因素包括血脂异常、糖尿病、高血压、吸烟、肥胖、慢性肾病、慢性感染、高C反应蛋白和高同型半胱氨酸血症。通过改变风险因素可以预防CAD。本文定义了CAD的一级、二级和三级预防。它讨论了风险因素诱导动脉粥样硬化的机制。本文描述了CAD风险评分及其在选择CAD一级预防个体中的应用。已经描述了CAD一级、二级和三级预防的指南。改变风险因素并使用CAD预防指南将预防、逆转和减缓CAD的进展,提高患者的生活质量,并降低医疗保健成本。

相似文献

1
Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease.
Int J Angiol. 2021 Aug 25;30(3):177-186. doi: 10.1055/s-0041-1731273. eCollection 2021 Sep.
2
Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.
Atherosclerosis. 2017 Jan;256:29-34. doi: 10.1016/j.atherosclerosis.2016.11.008. Epub 2016 Nov 9.
8
Secondary prevention of coronary artery disease with antimicrobials: current status and future directions.
Am J Cardiovasc Drugs. 2002;2(2):107-18. doi: 10.2165/00129784-200202020-00004.
9
Treatment of chronic CAD--do the guidelines (ESC, AHA) reflect daily practice?
Herz. 2009 Feb;34(1):39-54. doi: 10.1007/s00059-009-3209-6.
10
Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease.
Pharmacoeconomics. 1999 Jan;15(1):47-74. doi: 10.2165/00019053-199915010-00004.

引用本文的文献

2
Differences in severity of diffuse and focal coronary stenosis between visual and quantitative assessment.
Front Cardiovasc Med. 2024 Dec 16;11:1501576. doi: 10.3389/fcvm.2024.1501576. eCollection 2024.
5
Association between blood phosphorus level and adverse outcomes in patients with coronary artery disease: A meta-analysis.
Heliyon. 2024 Sep 26;10(19):e38565. doi: 10.1016/j.heliyon.2024.e38565. eCollection 2024 Oct 15.
7
The Impact of Modern Anti-Diabetic Treatment on Endothelial Progenitor Cells.
Biomedicines. 2023 Nov 14;11(11):3051. doi: 10.3390/biomedicines11113051.
8
Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: State-of-the-Art Review.
JACC CardioOncol. 2023 Oct 17;5(5):553-569. doi: 10.1016/j.jaccao.2023.08.008. eCollection 2023 Oct.
10
Development and External Validation of Nomogram to Identify Risk Factors for CHD in T2DM in the Population of Northwestern China.
Diabetes Metab Syndr Obes. 2023 May 4;16:1271-1282. doi: 10.2147/DMSO.S404683. eCollection 2023.

本文引用的文献

1
Neovascularization: The Main Mechanism of MSCs in Ischemic Heart Disease Therapy.
Front Cardiovasc Med. 2021 Jan 26;8:633300. doi: 10.3389/fcvm.2021.633300. eCollection 2021.
2
AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment.
Int J Angiol. 2020 Sep;29(3):156-167. doi: 10.1055/s-0040-1710045. Epub 2020 May 14.
3
Circulating cell adhesion molecules in metabolically healthy obesity.
Int J Obes (Lond). 2021 Feb;45(2):331-336. doi: 10.1038/s41366-020-00667-4. Epub 2020 Sep 1.
5
AGE-RAGE stress play a role in aortic aneurysm: A comprehensive review and novel potential therapeutic target.
Rev Cardiovasc Med. 2019 Dec 30;20(4):201-208. doi: 10.31083/j.rcm.2019.04.57.
7
Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
Int J Hypertens. 2019 May 2;2019:3159283. doi: 10.1155/2019/3159283. eCollection 2019.
9
Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis.
Ann Vasc Dis. 2018 Sep 25;11(3):253-258. doi: 10.3400/avd.ra.18-00070.
10
Practice setting and secondary prevention of coronary artery disease.
Arch Med Sci. 2018 Aug;14(5):979-987. doi: 10.5114/aoms.2017.65236. Epub 2017 Jan 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验